Physician profile
Benjamin Powell
NPI 1225157886
$3,004.30
in general payments reported to CMS, 2019-2025
25 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $153 · 2021: $755 · 2022: $745 · 2023: $331 · 2024: $403 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,044.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $828.87 | 2019-2023 | Trudi Nav Cable |
| Optinose US, INC. | $466.25 | 2019-2022 | |
| Intersect Ent, INC. | $292.20 | 2019-2022 | |
| Genzyme Corporation | $286.02 | 2021-2025 | |
| Integra Lifesciences Corporation | $163.83 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Glaxosmithkline, LLC. | $137.78 | 2023-2024 | Nucala |
| Aerin Medical INC. | $115.51 | 2024 | |
| Ethicon US, LLC | $111.66 | 2019 | |
| Stryker Corporation | $102.15 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $93.01 | 2019-2023 | Dupixent |
| Inspire Medical Systems, INC. | $54.35 | 2025 | Inspire |
| Kerecis Limited | $48.20 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Polynovo North America LLC | $44.72 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $40.58 | 2021-2023 | |
| Medtronic, INC. | $39.33 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $28.59 | 2023 | Ryaltris |
| Phathom Pharmaceuticals, INC. | $23.34 | 2025 | Voquezna |
| Smith+Nephew, INC. | $20.91 | 2024 | Halo |
| Arbor Pharmaceuticals, INC. | $16.31 | 2020 | |
| Xoran Technologies LLC | $16.26 | 2020 | |
| Olympus America INC. | $16.11 | 2019 | |
| Bioventus LLC | $15.34 | 2023 | |
| Neurent Medical Limited | $14.85 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Ambu INC. | $14.44 | 2025 | |
| Hologic Sales and Service, LLC | $13.69 | 2024 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.